Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis.
Saved in:
| Title: | Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis. |
|---|---|
| Authors: | Xu, Yitian1, Wang, Lihua1, Zimmerman, Matthew D.2, Chen, Kai-Yuan3,4, Huang, Lu5, Fu, Dah-Jiun6, Kaya, Firat2, Rakhilin, Nikolai3,4, Nazarova, Evgeniya V.5, Bu, Pengcheng7, Dartois, Veronique2, Russell, David G.5 dgr8@cornell.edu, Shen, Xiling1,3,4 xiling.shen@duke.edu |
| Source: | PLoS Pathogens. 4/26/2018, Vol. 14 Issue 4, p1-21. 21p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 15537366 |
|---|---|
| DOI: | 10.1371/journal.ppat.1006974 |
